Effects of nifedipine on the venodilatory response to nitroglycerin

The American Journal of Cardiology
J A Gascho, W P Apollo

Abstract

The venodilatory effect of nifedipine 10 mg orally and the venodilatory effect of nitroglycerin 0.8 mg spray after pretreatment with nifedipine were assessed in 15 healthy men aged 22 to 41 years. Compared to placebo, nifedipine caused arteriolar dilation but did not venodilate (control VV[30] 3.67 +/- 0.24 [mean +/- standard error of the mean], after nifedipine VV[30] 3.41 +/- 0.22 cc/100 cc arm). The venodilatory effect of nitroglycerin was not altered by pretreatment with nifedipine. VV[30] increased by 0.72 +/- 0.14 cc/100 cc arm after nitroglycerin in subjects pretreated with placebo compared to 0.70 +/- 0.09 cc/100 cc arm in subjects pretreated with nifedipine. These results suggest that, at a dose of 10 mg, nifedipine does not venodilate and the venodilatory effect of nitroglycerin is not altered by pretreatment with nifedipine.

Citations

Oct 31, 2002·The Australian and New Zealand Journal of Psychiatry·Brett M McDermott, Lyle J Palmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.